CLINICAL_TRIALS
trial_result
· 2023-12-20
Clinical Trial Update: AkLief Evaluation in Acne-induced Post-Inflammatory Hyperpigmentation [Phase 4]
Summary
Phase 4 trial update for AkLief in acne vulgaris with evaluation of acne-induced post-inflammatory hyperpigmentation completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Galderma R&D | Conditions: Acne Vulgaris | Phase 4 | Status: COMPLETED | Results posted: 2023-12-20